Volume: 11 Issue: 1
Year: 2023, Page: 30-34, Doi: https://doi.org/10.47799/pimr.1101.05
Received: March 25, 2022 Accepted: Aug. 15, 2022 Published: Aug. 15, 2022
Background: The impact of uric acid as a stand-alone risk factor for non-communicable illness has been debated for decades. Strong free radical scavengers like hydroxyl ions, peroxynitrite, and other antioxidants like ascorbic acid are all scavenged by serum uric acid. Neuroprotective agents include uric acid and its connection to ischemic stroke is still debatable. Therefore, the current study tried to evaluate the serum uric levels in acute ischemic stroke patients.
Methods: Patients with acute stroke were included in the trial, thus if rTPA was given to them, it was noted. The patient's baseline blood pressure was taken (in a supine position). All acute stroke patients had blood drawn within 24 hours of admission to assess their lipid profiles, fasting blood sugar levels, and uric acid levels. A neurologist assessed each patient, and computer tomography (CT) and magnetic resonance imaging were used to distinguish between ischemic stroke and other types of stroke (MRI).
Results: Serum UA levels were found to be significantly higher in stroke patients, with 77.5 percent of patients having high levels (>6 mg/dL) compared to 30.0 percent of controls. When compared to the controls, the mean serum UA level in patients was considerably higher (p=0.0212). Multiple logistic regression analysis was used to determine the relationship between serum UA levels and outcome. Independent of other prognostic criteria, patients with high serum UA levels had a significantly worse outcome.
Conclusion: A significant relationship exists between high serum UA levels and ischemic stroke, stroke subtypes (excluding lacunar stroke), and poor outcomes. Finding and managing modifiable risk factors for stroke has advanced quite a bit. Hyperuricemia could be therapeutically targeted in the same manner that other risk factors, such as dyslipidemia and blood pressure, are regularly treated after stroke.
Keywords: Serum Uric Acid, Acute Ischemic Stroke, Hyperuricemia, Dyslipidemia
Group, Gbdndc . 2015. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study. Lancet Neurol 16:877–97.
Collaborators, Gbdrf . 2017. Global, regional, and national comparative risk assessment of 84 behavioral, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study. Lancet 392:1923–94.
Feigin, V L, Krishnamurthi, R V, Parmar, P, Norrving, B, Mensah, G A & Bennett, D A . 2015. Update on the global burden of ischemic and hemorrhagic stroke in 1990-2013: the GBD 2013 study. Neuroepidemiology 45:161–76.
Barr, W G . 1990. Uric acid. In: Walker HK, Hall WD & Hurst JW , eds. Clinical Methods. The History, Physical, and Laboratory Examination. (pp. 760-763)
Heo, S H & Lee, S H . 2010. High levels of serum Uric acid are associated with silent brain infarction. Jaurnal of the Neurol Scien 297:6–15.
Amaro, S, Urra, X & Gomez- Choco, M . 2011. Uric Acid Levels Are Relevant in Patients with Stroke Treated with Thrombolysis. Stroke 42:28–32.
Ogbera, A & Azenabor, A . 2010. Hyperuricemia and the metabolic syndrome in type 2 DM. Diabetol Metab Syndr 2:24–30.
Roddy, E & Choi, H K . 2014. Epidemiology of gout. Rheum Dis Clin North Am 40:155–175.
Seet, Rcs, Kasiman, K & Gruber, J . 2010. Is uric acid protective or deleterious in acute ischemic stroke? A prospective cohort study. Atherosclerosis 209:215–219.
Becker, B F . 1993. Towards the physiological function of uric acid. Free Radic Biol Med 14:615–631.
Kamei, K, Konta, T & Hirayama, A . 2017. Associations between serum uric acid levels and the incidence of nonfatal stroke: a nationwide community-based cohort study. Clin Exp Nephrol 21:497–503.
Storhaug, H M, Norvik, J V & Toft, I . 2013. Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: a gender-specific analysis from The Tromso Study. BMC Cardiovasc Disord 13:115.
Gerber, Y, Tanne, D, Medalie, J H & Goldbourt, U . 2006. Serum uric acid and long-term mortality from stroke, coronary heart disease, and all causes. Eur J Cardiovasc Prev Rehabil 13:193–198.
Hong, J M, Bang, O Y, Chung, C S, Joo, I S, Gwag, B J & Ovbiagele, B . 2010. Influence of recanalization on uric acid patterns in acute ischemic stroke. Cerebrovasc Dis 29(5):431–470.
Amaro, S, Urra, X, Gómez-Choco, M, Obach, Víctor, Cervera, Álvaro & Vargas, Martha . 2011. Uric acid levels are relevant in patients with stroke treated with thrombolysis. Stroke 42(1):28–32.
Yanyan, Z, Bhavik, P & Hyon, C . 2010. Prevalence of Hyperuricemia in the US General Population: The National Health and Nutrition Examination Survey (NHANES) 1999-2008. Arthritis and Rheumatism 62(10):1363.
Uaratanawong, S, Suraamornkul, S, Angkeaw, S & Uaratanawong, R . 2011. Prevalence of hyperuricemia in Bangkok population. Clin Rheumatol 30(7):887–93.
Conen, D, Wietlisbach, V, Bovet, P, Shamlaye, C, Riesen, W, Paccaud, F & Burnier, M . 2004. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health 4:9.
Dimitroula, H V, Hatzitolios, A I & Karvounis, H I . 2008. The role of uric acid in stroke: the issue remains unresolved. Neurologist 14(4):238–280.
Bansal, B C, Gupta, R R & Bansal, M R . 1975. Serum lipids and uric acid relationship in ischemic thrombotic cerebrovascular disease. Stroke 6:304–307.
Kim, S Y, Guevara, J P & Kim, K M . 2009. Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum 61(7):885–92.
Kanellis, J & Johnson, R J . 2003. Editorial comment-Elevated uric acid and ischemic stroke: accumulating evidence that it is injurious and not neuroprotective. Stroke 34(8):1956–57.
Proctor, P H . 2008. Uric acid: neuroprotective or neurotoxic? Stroke 39(5).
Dawson, J, Quinn, T, Lees, K & Walters, M . 2008. The continued Yin and Yang of uric acid. Stroke 39:9.
Kim, S Y, Guevara, J V & Kim, K M . 2008. Hyperuricemia and Risk of stroke: A Systematic Review and Hariklia VD, Apostolos H, Haralambosk. The Role of Uric Acid in Stroke. The issue Remains Unresolved. The Neurologist 14:238–242.
Milionis, H J, Kalantzi, K J & Goudevenos, J A . 2005. Serum uric acid levels and risk for acute ischaemic non-embolic stroke in elderly subjects. J Intern Med 258:435–476.
De Leeum, P W, Thijs, L & Birkenhager, W H . 2002. systolic hypertension in Europe (Syst-Eur) trial investigators, Prognostic significance of renal function in elderly patients with isolated systolic hypertension, results from the Syst-Eur trial. Am Soc Nephrol 13:2213–2234.
Weir, C, Muir, S, Walters, M & Lees, K R . 2003. Serum urate is an independent predictor of poor outcomes and future vascular events after acute stroke. Stroke 34:1951–57.
Prashanthi K, G KA. Estimation of serum uric acid level in acute ischemic stroke. Perspectives in Medical Research. 2023;11(1):30-34 DOI: 10.47799/pimr.1101.05